2026-02-04 Steering Committee Meeting Notes

Stakeholder group

SHIELD organization

Name of SHIELD member

organization designation

Industry Entity

Labgnostic, Inc.

Steve Box

primary

alternate

Epic

Dan Rutz

primary

alternate

Biomerieux

Xavier Gansel

primary

alternate

Roche

Nick Decker

primary

Roche

Open

alternate

Healthcare Provider

Indiana University/Indiana University Health/Association for Molecular Pathology

Mehdi Nassiri, MD

primary

University of Wisconsin-Madison

Andrea Pitkus, PhD, MLS(ASCP)CM, FAMIA - regrets

primary

UT Southwestern Medical Center

Hung Luu

primary

UNMC

Scott Campbell

primary

Longtime Lab Professional

Carmen Pugh - regrets

primary

Sonic Healthcare

Eric Crugnale - regrets

primary

Former Quest Diagnostics

Collom, Craig D

primary

Patient Advocate

 OPEN

OPEN

individual

Standards Organization

SNOMED International

Jim Case

primary

Monica Harry - regrets

alternate

Regenstrief Institute

Marjorie Rallins

primary

Eza Hafeza- regrets

alternate

HL7

Julia Skapik

primary

alternate

Professional Organization

Association of Public Health Laboratories

Riki Merrick

primary

Christina Gallegos

alternate

Logica

Stan Huff

primary

alternate

CAP

Raj Dash

primary

alternate

AMP

Robyn Temple

primary

alternate

Governmental - non Voting

CMS

Michael Smalara

primary

Open

alternate

ASTP/ONC

Sara Armson

primary

 OPEN

alternate

CDC

Hubert Vesper (/DDNID/NCEH/DLS)

primary

Jasmine Chaitram

alternate

NLM

OPEN

primary

OPEN

alternate

FDA

Keith Campbell

primary

alternate

ADLM

Li Zha

Quorum evaluation (two-thirds (2/3) of the Voting Representatives shall be necessary to constitute a quorum for the transaction of business)

Currently we have 17 named members (1 open slot, future 3 openings), so 2/3 = 11 is quorum (excluding chair and government members).

# of voting member per charter: 13 - 21

# of non-voting members per charter: 7

Open Meeting

12:09 PM ET - no quorum - Adjourn 12:56 PM ET

Steering Committee Membership

• Proposed Charter Updates to Article 3 Section 4 - January 2026Preview

  • consider what it means for organizational members to “term out” - for some stakeholder groups that might be applicable, but for SDOs and our federal partners for example we need to keep the ones that are relevant engaged

  • consider what benefit we were looking for when we decided on term limits, especially when some members have very specific expertise

• Nominations so far on 2026 SC tab = review participation for 2025: SC Participation trackerPreview

• Confluence page to collect Ideas for the longevity of SHIELD Community and workPreview:

  • need to clarify stakeholder incentives to ensure participation

    • for academia paper publication (find a journal that we might approach to be the “SHIELD” voice

    • influence / comments on upcoming regulation with the voice of all stakeholders in the lab data exchange space

Vision 2030 work

https://docs.google.com/document/d/11A9VyhtSGm9dCjJNOi7_eJzz3gPDMYhkmNCoQNVbxuo/edit?tab=t.0#heading=h.yp9lsvo5yvsf

Discussion today:

Give folks time to prep and use the Feb 10 call to complete this draft

Next steps:

• Serge has been invited to the SC meeting on Feb 18, 2026

Review SHIELD WG Deliverables and Milestone Grid

THANK YOU to all the WG Chairs for their effort in moving SHIELD work forward!!!

Vocab And Standards WG next calls and call information?

Next calls

All SHIELD Calls

• Feb 24, 2026

General Updates: 2024 - WG Chairs please make sure we have material for updates (at least notes we can link to)

Special Topic:

Feb 10, 2026 - Needed for more Vision 2030 work

Mar 10, 2026 - Any Topic, maybe update from ASTP Annual Meeting?

Steering Committee:

Feb 18, 2026

CDC Forum Call on Mar 3, 2026 12 - 1 PM ET with Topic: UDI in HL7.

USCDI V7 draft published

• comments due by Apr 13, 2026

• Started discussion today:

  • ASTP/ONC meeting will have a session introducing the V7 changes:

    • 2 new data classes:

      • Adverse Events (with 2 of the new data elements) - could include lab results

      • Healthcare Information Attributes (with 2 new and 2 moved data elements)

    • 29 new data elements + 1 very revised and renamed one (Smoking Status → Tobacco Use)

  • suggested improved tooling to support:

    • synonyms of data element names (Example: Performance Time could benefit from that, to indicate that for the lab use case this is Specimen Collection Date/Time)

    • remove data classes and only have data elements that can have tags indicating whihc of the use cases they are needed for (or maybe some data classes could remain and they could act as a grouper for common data elements needed in a use case), so that an EHR-s developer interested in implementing/certifying to a particular use case can easily find the list of elements functionally required to support that use case

  • Discussed how some definitions are very vauge (example Laboratory Orders) - Sara mentioned that is on purpose, so that implementers can figure out what elements are appropriate for their use case rather than overspecifying

• Collect comments here: USCDI Draft-V7 FeedbackPreview

Placeholder to get back to later

• Antimicrobial result reporting - CAP Informatics Commitee will request feedback from Standards and Vocab WG

  • Any updates from CAP?

• Other presentations to folks at FDA?

  • Data Standards Review Committee of the FDA – work with Helena Sviglin

  • FDA Scientific Computing Board (SCB)

  • Compass group lab